NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021-Reference-Cited by-全球学者库

NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

Published:2021-03 Issue:3 Volume:19 Page:254-266
ISSN:1540-1405
Container-title:Journal of the National Comprehensive Cancer Network
language:
Short-container-title:

Author:

Ettinger David S.¹,Wood Douglas E.²,Aisner Dara L.³,Akerley Wallace⁴,Bauman Jessica R.⁵,Bharat Ankit⁶,Bruno Debora S.⁷,Chang Joe Y.⁸,Chirieac Lucian R.⁹,D’Amico Thomas A.¹⁰,Dilling Thomas J.¹¹,Dowell Jonathan¹²,Gettinger Scott¹³,Gubens Matthew A.¹⁴,Hegde Aparna¹⁵,Hennon Mark¹⁶,Lackner Rudy P.¹⁷,Lanuti Michael¹⁸,Leal Ticiana A.¹⁹,Lin Jules²⁰,Loo Jr Billy W.²¹,Lovly Christine M.²²,Martins Renato G.²,Massarelli Erminia²³,Morgensztern Daniel²⁴,Ng Thomas²⁵,Otterson Gregory A.²⁶,Patel Sandip P.²⁷,Riely Gregory J.²⁸,Schild Steven E.²⁹,Shapiro Theresa A.¹,Singh Aditi P.³⁰,Stevenson James⁷,Tam Alda⁸,Yanagawa Jane³¹,Yang Stephen C.¹,Gregory Kristina M.³²,Hughes Miranda³²

Affiliation:

1. 1The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;

2. 2Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance;

3. 3University of Colorado Cancer Center;

4. 4Huntsman Cancer Institute at the University of Utah;

5. 5Fox Chase Cancer Center;

6. 6Robert H. Lurie Comprehensive Cancer Center of Northwestern University;

7. 7Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute;

8. 8The University of Texas MD Anderson Cancer Center;

9. 9Dana-Farber/Brigham and Women’s Cancer Center;

10. 10Duke Cancer Institute;

11. 11Moffitt Cancer Center;

12. 12UT Southwestern Simmons Comprehensive Cancer Center;

13. 13Yale Cancer Center/Smilow Cancer Hospital;

14. 14UCSF Helen Diller Family Comprehensive Cancer Center;

15. 15O'Neal Comprehensive Cancer Center at UAB;

16. 16Roswell Park Comprehensive Cancer Center;

17. 17Fred & Pamela Buffett Cancer Center;

18. 18Massachusetts General Hospital Cancer Center;

19. 19University of Wisconsin Carbone Cancer Center;

20. 20University of Michigan Rogel Cancer Center;

21. 21Stanford Cancer Institute;

22. 22Vanderbilt-Ingram Cancer Center;

23. 23City of Hope National Medical Center;

24. 24Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine;

25. 25The University of Tennessee Health Science Center;

26. 26The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute;

27. 27UC San Diego Moores Cancer Center;

28. 28Memorial Sloan Kettering Cancer Center;

29. 29Mayo Clinic Cancer Center;

30. 30Abramson Cancer Center at the University of Pennsylvania;

31. 31UCLA Jonsson Comprehensive Cancer Center; and

32. 32National Comprehensive Cancer Network.

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines regarding targeted therapies, immunotherapies, and their respective biomarkers.

Publisher

Harborside Press, LLC

Subject

Oncology

Link

https://jnccn.org/downloadpdf/journals/jnccn/19/3/article-p254.xml

Cited by 628 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MAFF confers vulnerability to cisplatin-based and ionizing radiation treatments by modulating ferroptosis and cell cycle progression in lung adenocarcinoma;Drug Resistance Updates;2024-03

2. LncRNA-HOXC-AS2 regulates tumor-associated macrophage polarization through the STAT1/SOCS1 and STAT1/CIITA pathways to promote the progression of non-small cell lung cancer;Cellular Signalling;2024-03

3. 18F-FDG PET/CT characteristics of IASLC grade 3 invasive adenocarcinoma and the value of 18F-FDG PET/CT for preoperative prediction: a new prognostication model;Nuclear Medicine Communications;2024-02-05

4. Non-invasive decision support for clinical treatment of non-small cell lung cancer using a multiscale radiomics approach;Radiotherapy and Oncology;2024-02

5. The Role of Systemic Therapy in Patients with Advanced Non-small Cell Lung Cancer and a Poor Eastern Cooperative Oncology Group Performance Status;Clinical Oncology;2024-02